Ranolazine
NDC 50268-722, Ranolazine, tablet, film coated, extended release, from AvPAK.
- Product NDC
- 50268-722
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209953
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-722 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANOLAZINE500 mg/1
Pharmacologic classes
Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-722-15 | 50268072215 | 50 BLISTER PACK in 1 BOX (50268-722-15) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (50268-722-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e92350e8-5b0b-95d3-e053-2995a90a959bNADAC price for package 50268072215
GET /v1/drugs/nadac/50268072215
Use it
Look up 50268-722 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-722 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-722. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.